Respiratory viruses are the most common cause of sickness in humans, with considerable morbidity and mortality rates around the world. Community-based investigations undertaken over the last five decades or so demonstrate that common respiratory agents from several virus families are the primary etiological agents of acute respiratory infections (ARIs). The severity of viral respiratory illness varies, but it is more common in elderly people and new-borns. Despite the fact that respiratory viruses cause a wide variety of diseases, there are now just a few preventive or therapeutic strategies available. Recent discoveries in respiratory virus molecular and cell biology, on the other hand, should lead to the development of helpful therapies.
Title : Detection and genetic characterization of emerging viruses in symptomatic children with enteritis
Amoroso Maria Grazia , Zooprofilactic and Experimental Institute of Southern Italy, Italy
Title : Regulation of IRF3 functions to control viral infections
Saurabh Chattopadhyay, The University of Toledo, United States
Title : Post-vaccination antibody responses against SARS-CoV-2 in patients with liver cirrhosis. What do we know so far?
Theodoros Androutsakos, National and Kapodistrian University of Athens, Greece
Title : Single-virus sorting by Flow Cytometry: a methodology to elucidate the virosphere
Oscar Fornas, Pompeu Fabra University and Centre for Genomic Regulation in Barcelona, Spain
Title : Evolutionary trajectory and origin of SARS-CoV-2
Anyou Wang, University of Memphis, United States
Title : Post- vaccination humoral immune responses against SARS-CoV-2 in patients with haematologic malignancies
Ioanna E. Stergiou, National and Kapodistrian University of Athens, Greece